Searching for Novel Janus Kinase-2 Inhibitors Using a Combination of Pharmacophore Modeling, 3D-QSAR Studies and Virtual Screening

By  

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 3, 2017-01 ,pp. : 268-294

Bentham Science Publishers

Access to resources Recommend Favorite

Highly selective Janus kinase 3 inhibitors based on a pyrrolo[2,3-d]pyrimidine scaffold: evaluation of WO2013085802

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 1, 2014-01 ,pp. : 121-125

Informa Healthcare

Access to resources Recommend Favorite

Tyrosine kinase: novel target in Ewing's sarcoma?

By  

Inpharma, Vol. 1, Iss. 1371, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

In Vivo Target Validation: Methodology and Case Studies on the Janus Kinase Tyk2

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 1, 2007-01 ,pp. : 29-45

Bentham Science Publishers

Access to resources Recommend Favorite

Pyrrolo[2,3]pyrimidine inhibitors of Janus kinase 3 protein tyrosine kinase

By  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 7, 2003-07 ,pp. : 1087-1092

Informa Healthcare

Access to resources Recommend Favorite